Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Intra-Cellular Therapies, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$0.15 | $0.03 | -$0.08 |
| Q2 2025 | 2 | $0.05 | $0.05 | $0.05 |
| Q3 2025 | 2 | $0.10 | $0.10 | $0.10 |
| Q4 2025 | 3 | $0.27 | $0.27 | $0.27 |
Intra-Cellular Therapies, Inc. Earnings Date And Information
Intra-Cellular Therapies, Inc. last posted its earnings results on Friday, February 21st, 2025. The company reported $-0.16 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0.08. The company had revenue of 199.22 M for the quarter and had revenue of 680.85 M for the year. Intra-Cellular Therapies, Inc. has generated $-1 earnings per share over the last year ($-0.72 diluted earnings per share) and currently has a price-to-earnings ratio of -182.12. Intra-Cellular Therapies, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based on prior year's report dates.
Intra-Cellular Therapies, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/20/2025 | Q4 2024 | N/A | $0.56 | N/A | $193.40 M | $199.22 M |
| 10/30/2024 | Q3 2024 | -$0.18 | -$0.25 | -0.07 | $172.30 M | $175.16 M |
| 08/07/2024 | Q2 2024 | -$0.18 | -$0.16 | 0.02 | $157.90 M | $161.39 M |
| 05/07/2024 | Q1 2024 | -$0.31 | -$0.16 | 0.15 | $141.41 M | $144.87 M |
| 02/22/2024 | Q4 2023 | -$0.44 | -$0.30 | 0.14 | $135.68 M | $131.51 M |
| 11/02/2023 | Q3 2023 | -$0.59 | -$0.25 | 0.34 | $119.25 M | $125.81 M |
| 08/03/2023 | Q2 2023 | -$0.62 | -$0.45 | 0.17 | $106.45 M | $110.13 M |
| 05/04/2023 | Q1 2023 | -$0.63 | -$0.46 | 0.17 | $92.11 M | $94.73 M |
| 03/01/2023 | Q4 2022 | -$0.62 | -$0.39 | 0.23 | $87.01 M | $87.43 M |
| 11/03/2022 | Q3 2022 | -$0.86 | -$0.57 | 0.29 | $65.99 M | $71.87 M |
| 08/09/2022 | Q2 2022 | -$0.79 | -$0.89 | -0.1 | $49.04 M | $55.07 M |
| 05/10/2022 | Q1 2022 | -$0.93 | -$0.78 | 0.15 | $33.66 M | $34.76 M |
| 03/01/2022 | Q4 2021 | -$1.05 | -$1.05 | 0 | $25.03 M | $25.52 M |
| 11/09/2021 | Q3 2021 | -$0.89 | -$0.95 | -0.06 | $22.08 M | $21.61 M |
| 08/09/2021 | Q2 2021 | -$0.79 | -$0.85 | -0.06 | $19.03 M | $19.01 M |
| 05/10/2021 | Q1 2021 | -$0.81 | -$0.65 | 0.16 | $16.70 M | $15.58 M |
| 02/25/2021 | Q4 2020 | -$0.85 | -$0.76 | 0.09 | $11.82 M | $12.40 M |
| 11/09/2020 | Q3 2020 | -$0.96 | -$0.79 | 0.17 | $5.53 M | $7.37 M |
| 08/10/2020 | Q2 2020 | -$0.94 | -$0.96 | -0.02 | $2.92 M | $1.88 M |
| 05/07/2020 | Q1 2020 | -$0.98 | -$0.73 | 0.25 | $1.44 M | $882,516 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Intra-Cellular Therapies, Inc. Earnings: FAQ's
Intra-Cellular Therapies, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based offlast year's report dates.
The conference call for Intra-Cellular Therapies, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Intra-Cellular Therapies, Inc.'s latest earnings report can be read online.
Intra-Cellular Therapies, Inc. (:ITCI) has a recorded annual revenue of $680.85 M.
Intra-Cellular Therapies, Inc. (:ITCI) has a recorded net income of $-74,676,000.Intra-Cellular Therapies, Inc. has generated $-0.72 earnings per share over the last four quarters.
Intra-Cellular Therapies, Inc. (:ITCI) has a price-to-earnings ratio of -182.12 and price/earnings-to-growth ratio is -1.84.